4 completed. 2 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow fomivirsen: new trials by email Literature Review of fomivirsen trials Research Report on fomivirsen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes Fomivirsen sodium - Cytomegalovirus Retinitis, HIV Infections | Phase 2 | Completed | Ionis Pharmaceuticals, Inc. | 2005-06-24 | ||
| A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis Fomivirsen sodium - Cytomegalovirus Retinitis, HIV Infections | Not applicable | Completed | Ionis Pharmaceuticals, Inc. | 2005-06-24 | ||
| A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes Fomivirsen sodium - Cytomegalovirus Retinitis, HIV Infections | Not applicable | Completed | Ionis Pharmaceuticals, Inc. | 60 | 2005-06-24 | |
| A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) Fomivirsen sodium, Ganciclovir - Cytomegalovirus Retinitis, HIV Infections | Phase 2 | Completed | Ionis Pharmaceuticals, Inc. | 194 | 2005-06-24 |
Cytomegalovirus Retinitis (4) · HIV Infections (4) · AIDS-Related Opportunistic Infections (3) · Acquired Immunodeficiency Syndrome (3) · Multiple Acyl Coenzyme A Dehydrogenase Deficiency (1)
Ionis Pharmaceuticals, Inc. (4)
United States (4)